-transparent.png){kind=logo}
3,9-Dihydroxy-5H-benzofuro[3,2-c]quinoline-6-one (KCA-012), the chemical structure of which is closely similar to that of the phytoestrogen coumestrol, inhibited parathyroid hormone-, 1 alpha,25-dihydroxyvitamin D3- and prostaglandin E2-induced bone resorption of cultured fetal rat bones. KCA-012 also increased the calcium content of 9-day chick embryonic femur cultured in vitro. KCA-012 did not show any estrogenic activity as determined by an increase in the uterine weight of ovariectomized rats, whereas coumestrol did. These results indicate that KCA-012 has no estrogenic activity and has unique effects of inhibiting bone resorption and stimulating bone mineralization.
Related Publications
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
July 1995,
Biological & pharmaceutical bulletin,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
April 1979,
Endocrinology,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
June 1982,
Toxicology and applied pharmacology,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
January 1987,
The American journal of physiology,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
June 1968,
Growth,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
March 1995,
Toxicology,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
January 1974,
Calcified tissue research,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
February 1996,
American journal of therapeutics,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
September 1976,
Clinical orthopaedics and related research,
N Tsutsumi, and
K Kawashima, and
H Nagata, and
A Ujiie, and
H Endo
August 1964,
Science (New York, N.Y.),
